Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 147, Issue 3, 2009, Pages 371-378

  Locatelli, Franco ^a   Testi, Anna M ^b   Bernardo, Maria Ester ^a   Rizzari, Carmelo ^c   Bertaina, Alice ^a   Merli, Pietro ^a   Pession, Andrea ^d   Giraldi, Eugenia ^e   Parasole, Rosanna ^f   Barberi, Walter ^b   Zecca, Marco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e OSPEDALI RIUNITI   (Italy)

^f SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

Author keywords

Acute lymphoblastic leukaemia; Allogeneic haematopoietic stem cell transplantation; Childhood haematological malignancies; Clofarabine; Combination therapy; Refractory relapsed disease

Indexed keywords

ACICLOVIR; AMOXICILLIN; BUSULFAN; CIPROFLOXACIN; CLAVULANIC ACID; CLOFARABINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUCONAZOLE; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CARDIOTOXICITY; CAUSE OF DEATH; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE RELEASE SYNDROME; DISEASE COURSE; DRUG HYPERSENSITIVITY; FEBRILE NEUTROPENIA; FEMALE; FUNGAL PNEUMONIA; HEMORRHAGIC CYSTITIS; HERPES VIRUS INFECTION; HUMAN; HYPERBILIRUBINEMIA; INFECTIOUS PNEUMONIA; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LIVER DYSFUNCTION; LIVER TOXICITY; LUNG TOXICITY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MYCOSIS; NEPHROTOXICITY; NEUROTOXICITY; OVERALL SURVIVAL; PRE B LYMPHOCYTE; PRE T LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; PYREXIA IDIOPATHICA; SCHOOL CHILD; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ADENINE NUCLEOTIDES; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARABINONUCLEOSIDES; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70349904430     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07882.x     Document Type: Article

References (32)

1. Ascioglu, S., Rex, J.H., de Pauw, B., Bennett, J.E., Bille, J., Crokaert, F., Denning, D.W., Donnelly, J.P., Edwards, J.E., Erjavec, Z., Fiere, D., Lortholary, O., Maertens, J., Meis, J.F., Patterson, T.F., Ritter, J., Selleslag, D., Shah, P.M., Stevens, D.A. Walsh, T.J. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clinical Infectious Diseases, 34, 7 14.
2. Beesley, A.H., Palmer, M.L., Ford, J., Weller, R.E., Cummings, A.J., Freitas, J.R., Firth, M.J., Perera, K.U., de Klerk, N.H. Kees, U.R. (2007) In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia. British Journal of Haematology, 137, 109 116.
3. Chessells, J.M., Veys, P., Kempski, H., Henley, P., Leiper, A., Webb, D. Hann, I.M. (2003) Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. British Journal of Haematology, 123, 396 405.
4. Conter, V., Schrappe, M., Aricò, M., Reiter, A., Rizzari, C., Dordelmann, M., Valsecchi, M.G., Zimmermann, M., Ludwig, W.D., Basso, G., Masera, G. Riehm, H. (1997) Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster groups. Journal of Clinical Oncology, 15, 2786 2791.
5. Conter, V., Aricò, M., Valsecchi, M.G., Basso, G., Biondi, A., Madon, E., Mandelli, F., Paolucci, G., Pession, A., Rizzari, C., Rondelli, R., Zanesco, L. Masera, G. (2000) Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995. Leukemia, 14, 2196 2204.
6. DeAngelo, D.J., Yu, D., Johnson, J.L., Coutre, S.E., Stone, R.M., Stopeck, A.T., Gockerman, J.P., Mitchell, B.S., Appelbaum, F.R. Larson, R.A. (2007) Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. Blood, 109, 5136 5142.
7. Einsiedel, H.G., von Stackelberg, A., Hartmann, R., Fengler, R., Schrappe, M., Janka-Schaub, G., Mann, G., Hahlen, K., Gobel, U., Klingebiel, T., Ludwig, W.D. Henze, G. (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. Journal of Clinical Oncology, 23, 7942 7950.
8. Estey, E., Thall, P., Andreeff, M., Beran, M., Kantarjian, H., O'Brien, S., Escudier, S., Robertson, L.E., Koller, C. Kornblau, S. (1994) Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. Journal of Clinical Oncology, 12, 671 678.
9. Faderl, S., Gandhi, V., O'Brien, S., Bonate, P., Cortes, J., Estey, E., Beran, M., Wierda, W., Garcia-Manero, G., Ferrajoli, A., Estrov, Z., Giles, F.J., Du, M., Kwari, M., Keating, M., Plunkett, W. Kantarjian, H. (2005) Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias. Blood, 105, 940 947.
10. Faderl, S., Ravandi, F., Huang, X., Garcia-Manero, G., Ferrajoli, A., Estrov, Z., Borthakur, G., Verstovsek, S., Thomas, D.A., Kwari, M. Kantarjian, H.M. (2008) A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood, 112, 1638 1645.
11. Gandhi, V., Plunkett, W., Weller, S., Du, M., Ayres, M., Rodriguez, Jr., C.O., Ramakrishna, P., Rosner, G.L., Hodge, J.P., O'Brien, S. Keating, M.J. (2001) Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells. Journal of Clinical Oncology, 19, 2142 2152.
12. Henze, G., Fengler, R., Hartmann, R., Kornhuber, B., Janka-Schaub, G., Niethammer, D. Riehm, H. (1991) Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood, 78, 1166 1172.
13. Hijiya, N., Franklin, J. Rytting, M. (2007) A phase I study of clofarabine in combination with cyclophosphamide and etoposide: a new regimen in pediatric patients with refractory or relapsed acute leukemia. Journal of Clinical Oncology (ASCO Meetings Abstracts), 25 (Suppl. 18S Abstract 9529.
14. Hijiya, N., Gaynon, P.S., Fernandez, M., Silverman, L.B., Thomson, B., Chu, R., Cooper, T., Kadota, R., Rytting, M., Steinherz, P.G., Shen, V., Jeha, S., Barry, E. Carroll, W.L. (2008) Durable remissions observed in a phase I/II study of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute leukemia. Blood (ASH Annual Meeting Abstracts), 112, Abstract 2925.
15. Jeha, S., Gandhi, V., Chan, K.W., McDonald, L., Ramirez, I., Madden, R., Rytting, M., Brandt, M., Keating, M., Plunkett, W. Kantarjian, H. (2004) Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood, 103, 784 789.
16. Jeha, S., Gaynon, P.S., Razzouk, B.I., Franklin, J., Kadota, R., Shen, V., Luchtman-Jones, L., Rytting, M., Bomgaars, L.R., Rheingold, S., Ritchey, K., Albano, E., Arceci, R.J., Goldman, S., Griffin, T., Altman, A., Gordon, B., Steinherz, L., Weitman, S. Steinherz, P. (2006) Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Journal of Clinical Oncology, 24, 1917 1923.
17. Kantarjian, H.M., Gandhi, V., Kozuch, P., Faderl, S., Giles, F., Cortes, J., O'Brien, S., Ibrahim, N., Khuri, F., Du, M., Rios, M.B., Jeha, S., McLaughlin, P., Plunkett, W. Keating, M. (2003) Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers. Journal of Clinical Oncology, 21, 1167 1173. (Pubitemid 46594149)
18. Kantarjian, H.M., Jeha, S., Gandhi, V., Wess, M. Faderl, S. (2007) Clofarabine: past, present, and future. Leukemia & Lymphoma, 48, 1922 1930.
19. Karp, J.E., Ricklis, R.M., Balakrishnan, K., Briel, J., Greer, J., Gore, S.D., Smith, B.D., McDevitt, M.A., Carraway, H., Levis, M.J. Gandhi, V. (2007) A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias. Blood, 110, 1762 1769. (Pubitemid 47443886)
20. Krance, R.A., Hurwitz, C.A., Head, D.R., Raimondi, S.C., Behm, F.G., Crews, K.R., Srivastava, D.K., Mahmoud, H., Roberts, W.M., Tong, X., Blakley, R.L. Ribeiro, R.C. (2001) Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. Journal of Clinical Oncology, 19, 2804 2811.
21. Larson, R.A. (2007) Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine. Seminars in Oncology, 34, S13 S20.
22. Moghrabi, A., Levy, D.E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V.K., Lipshultz, S.E., Neuberg, D.S., Gelber, R.D., Cohen, H.J., Sallan, S.E. Silverman, L.B. (2007) Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 109, 896 904.
23. Moricke, A., Reiter, A., Zimmermann, M., Gadner, H., Stanulla, M., Dordelmann, M., Loning, L., Beier, R., Ludwig, W.D., Ratei, R., Harbott, J., Boos, J., Mann, G., Niggli, F., Feldges, A., Henze, G., Welte, K., Beck, J.D., Klingebiel, T., Niemeyer, C., Zintl, F., Bode, U., Urban, C., Wehinger, H., Niethammer, D., Riehm, H. Schrappe, M. (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111, 4477 4489.
24. Paganin, M., Zecca, M., Fabbri, G., Polato, K., Biondi, A., Rizzari, C., Locatelli, F. Basso, G. (2008) Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia. Leukemia, 22, 2193 2200.
25. Pession, A., Valsecchi, M.G., Masera, G., Kamps, W.A., Magyarosy, E., Rizzari, C., van Wering, E.R., Lo Nigro, L., van der Does, A., Locatelli, F., Basso, G. Aricò, M. (2005) Long-term results of a randomized trial on extended use of high dose l-asparaginase for standard risk childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 23, 7161 7167.
26. Plunkett, W. Gandhi, V. (2001) Purine and pyrimidine nucleoside analogs. Cancer Chemotherapy and Biological Response Modifiers, 19, 21 45.
27. Pui, C.H. Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166 178.
28. Rizzari, C., Valsecchi, M.G., Aricò, M., Miniero, R., Messina, C., De Rossi, G., Testi, A.M., Mura, R., Galimberti, S., Biondi, A., Locatelli, F. Conter, V. (2004) Outcome of very late relapse in children with acute lymphoblastic leukemia. Haematologica, 89, 427 434.
29. Smith, M., Arthur, D., Camitta, B., Carroll, A.J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E.L., Link, M., Murphy, S., Pui, C.H., Pullen, J., Reamon, G., Sallan, S.E., Sather, H., Shuster, J., Simon, R., Trigg, M., Tubergen, D., Uckun, F. Ungerleider, R. (1996) Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 14, 18 24. (Pubitemid 26019992)
30. Spriggs, D.R., Stopa, E., Mayer, R.J., Schoene, W. Kufe, D.W. (1986) Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study. Cancer Research, 46, 5953 5958.
31. Warrell, R.P.J. Berman, E. (1986) Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity. Journal of Clinical Oncology, 4, 74 79.
32. Yamauchi, T., Nowak, B.J., Keating, M.J. Plunkett, W. (2001) DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4- hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clinical Cancer Research, 7, 3580 3589.